Axsome Therapeutics, Inc 10-K for FY2024
Axsome Therapeutics, Inc. (AXSM)
10-K
2025-02-18
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
Axsome Therapeutics, Inc filed this 10-K on February 18, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $385.69M
- up 42.5% from $270.6M a year earlier
- Net loss
- $287.22M
- compared with a net loss of $239.24M a year earlier
- Diluted EPS
- -$5.99
- compared with -$5.27 a year earlier